Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NxStage Medical is a kidney care and medical device company focused on dialysis technologies, particularly home hemodialysis systems and related consumables, software, and services. The business is best known for the NxStage System One portable hemodialysis platform and associated products such as PureFlow dialysate preparation systems, cartridges, and home therapy support tools. Historically an independent NASDAQ-listed company, NxStage was acquired by Fresenius Medical Care in February 2019 and now operates as part of Fresenius' kidney care portfolio. Its products are used for the treatment of end-stage renal disease and other renal conditions in home and clinical settings, with an emphasis on enabling more flexible and patient-centered dialysis care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NxStage Medical.